APA (7th ed.) Citation

S, C., Z, H., M, L., L, W., & J, L. (2024). Efficacy and safety of metronomic oral vinorelbine and its combination therapy as second- and later-line regimens for advanced non-small-cell lung cancer: A retrospective analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 26(12), 3202. https://doi.org/10.1007/s12094-024-03543-z

Chicago Style (17th ed.) Citation

S, Chen, He Z, Li M, Weng L, and Lin J. "Efficacy and Safety of Metronomic Oral Vinorelbine and Its Combination Therapy as Second- and Later-line Regimens for Advanced Non-small-cell Lung Cancer: A Retrospective Analysis." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26, no. 12 (2024): 3202. https://doi.org/10.1007/s12094-024-03543-z.

MLA (9th ed.) Citation

S, Chen, et al. "Efficacy and Safety of Metronomic Oral Vinorelbine and Its Combination Therapy as Second- and Later-line Regimens for Advanced Non-small-cell Lung Cancer: A Retrospective Analysis." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 26, no. 12, 2024, p. 3202, https://doi.org/10.1007/s12094-024-03543-z.